Published: May 8, 2026 at 8:57 am
The new corporate leadership team at Physiomics plc has painted a positive picture after ousting the previous board.
Physiomics is a mathematical modelling, data science and biometrics company which supports the development of new therapeutics and personalised medicine solutions.
Activist investor Mike Whitlow, now executive director of the listed firm, praised the professionalism of the wider team during its review of operations.
The firm also praised the professionalism of CEO Dr Peter Sargent, who was among those removed from the board, and said he had been “accommodating and supportive throughout the transition process”.
It added that discussions are ongoing regarding the extension of his contract with the company, which runs out later this month.
More than three-quarters of shareholders who voted agreed to remove former chair Dr Jim Millen, Dr Sargent, Shalabh Kumar and Dr Tim Corn, and to appoint Whitlow, Ian Bagnall and Nicholas Tulloch in their place.
This morning the firm rejected “recent unfounded market speculation concerning alleged substantial exit packages payable to former personnel”, adding: “The board confirms unequivocally that the company has made no payments outside of contractual entitlements to former directors or employees.”